Medicare's next round of drug negotiations
The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare negotiation. The CMS listed Ozempic, Rybelsus and Wegovy — all forms of semaglutide — at the top of the list of drugs for which Medicare will the negotiate the price of in 2025.
The Centers for Medicare & Medicaid Services Jan. 17 announced a record 24.2 million consumers selected health coverage ...
The Centers for Medicare & Medicaid Services on Friday released an informational bulletin with updated federal poverty level ...
Abe Sutton, a health policy aide in the first Trump administration, is likely to be named head of the Center for Medicare and ...
The Centers for Medicare & Medicaid Services (CMS) has issued the Calendar Year (CY) 2026 Advance Notice, proposing updates to payment policies ...
6d
The Centers for Medicare and Medicaid Services (CMS) selected Michigan as one of four states to participate in the Innovation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback